Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin's lymphoma (NHL) and represents between 4-8% of adult lymphomas. Recently an increase in its incidence to 1-2 cases/100,000 inhabitants/year has been observed. The first line of treatment is based on chemoimmunotherapy and depends on age and the initial stage at diagnosis. There are no second line or successive treatments. There are currently several drugs available that provide acceptable results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817526PMC
http://dx.doi.org/10.3332/ecancer.2016.627DOI Listing

Publication Analysis

Top Keywords

mantle cell
8
cell lymphoma
8
lymphoma mcl
8
diagnostic therapeutic
4
therapeutic update
4
update mantle
4
mcl analysis
4
analysis cases
4
cases treated
4
treated centre
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!